✦ LIBER ✦

Cytapheresis for the Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A Pilot Study of 21 Patients

✍ Scribed by Midori Hasegawa; Atsushi Ohashi; Nao Kabutan; Saori Hiramatsu; Masao Kato; Kazutaka Murakami; Makoto Tomita; Kunihiro Nabeshima; Yoshiyuki Hiki; Satoshi Sugiyama

Book ID: 111333876
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 106 KB
Volume: 10
Category: Article
ISSN: 1091-6660
DOI: 10.1111/j.1744-9987.2006.00404.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of myeloperoxidase-antineutr

Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α

✍ Daigoro Hirohama; Junichi Hoshino; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Ha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 219 KB

Imatinib mesylate, a new kid on the bloc

Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?

✍ A.-I. Kälsch; M. Soboletzki; W. H. Schmitt; F. J. Van Der Woude; A. Hochhaus; B. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Rituximab: Recommendations of the French

Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides

✍ Charles, Pierre; Bienvenu, Boris; Bonnotte, Bernard; Gobert, Pierre; Godmer, Pas 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 286 KB

Intravenous immunoglobulins for relapses

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open-label study of twenty-two patients

✍ Valérie Martinez; Pascal Cohen; Christian Pagnoux; Stéphane Vinzio; Alfred Mahr; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB